[The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations].
This article presents the current evidence- based recommendations for the use of these methods in clinical practice in NSCLC and malignant pleural mesothelioma.
PMID: 24615197 [PubMed - in process]
Source: Pneumonologia i Alergologia Polska - Category: Respiratory Medicine Authors: Jassem J, Biernat W, Bryl M, Chorostowska-Wynimko J, Dziadziuszko R, Krawczyk P, Kordek R, Kowalski DM, Krzakowski M, Olszewski W, Orłowski T, Ramlau R, Witold Rzyman WR Tags: Pneumonol Alergol Pol Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | Lung Cancer | Mesothelioma | Non-Small Cell Lung Cancer | Respiratory Medicine